About Chemo Mouthpiece
Chemo Mouthpiece is a company based in Closter (United States) founded in 2017 by David Yoskowitz. Chemo Mouthpiece has raised $15.9 million across 3 funding rounds. The company has 12 employees as of December 31, 2024. Chemo Mouthpiece offers products and services including Chemo Mouthpiece Device and Patient Kit. Chemo Mouthpiece operates in a competitive market with competitors including Protip Medical, ENT Biotech Solutions, APrevent, OTT Medical and Surgimed, among others.
- Headquarter Closter, United States
- Employees 12 as on 31 Dec, 2024
- Founders David Yoskowitz
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chemo Mouthpiece. Llc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.9 M (USD)
in 3 rounds
-
Latest Funding Round
$900 K (USD), Series A
Nov 05, 2024
-
Investors
Not available
-
Employee Count
12
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chemo Mouthpiece
Chemo Mouthpiece offers a comprehensive portfolio of products and services, including Chemo Mouthpiece Device and Patient Kit.
Cools mouth to reduce chemotherapy-induced oral mucositis pain.
Includes devices and tools for at-home oral cryotherapy use.
People of Chemo Mouthpiece
Unlock access to complete
Unlock access to complete
Funding Insights of Chemo Mouthpiece
Chemo Mouthpiece has successfully raised a total of $15.9M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $900 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Chemo Mouthpiece
Investment portfolio details for Chemo Mouthpiece
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chemo Mouthpiece
Detailed financials for Chemo Mouthpiece
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chemo Mouthpiece Comparisons
Peer comparison for Chemo Mouthpiece
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chemo Mouthpiece
Chemo Mouthpiece operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Protip Medical, ENT Biotech Solutions, APrevent, OTT Medical and Surgimed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable devices for larynx surgery are developed to reduce complications.
|
|
| Locked | Locked | Locked |
A disposable, single-use tool that cuts, cauterizes and removes tissue during tonsil and adenoid surgery
|
|
| Locked | Locked | Locked |
-
|
|
| Locked | Locked | Locked |
Offers professional architectural services for homeowners and commercial developers worldwide.
|
|
| Locked | Locked | Locked |
Develops innovative technologies for vocal cord nerve monitoring.
|
Detailed competitors of Chemo Mouthpiece
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chemo Mouthpiece
Complete news archive for Chemo Mouthpiece
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemo Mouthpiece
Chemo Mouthpiece was founded in 2017 and raised its 1st funding round 7 years after it was founded.
Chemo Mouthpiece is headquartered in Closter, United States. It is registered at Closter, New Jersey, United States.
David Yoskowitz is the current CEO of Chemo Mouthpiece. They have also founded this company.
Chemo Mouthpiece is a funded company, having raised a total of $15.9M across 3 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Chemo Mouthpiece is 12.
Chemo Mouthpiece was founded in 2017 and is headquartered in Closter, United States. A medical device known as the Chemo Mouthpiece is developed by the company to deliver cryotherapy across the entire oral cavity. This device is intended for patients receiving chemotherapy, where it addresses oral mucositis as a frequent side effect. Operations focus on the healthcare sector, specifically oncology support through targeted cooling technology.
Chemo Mouthpiece's top competitors include Protip Medical, ENT Biotech Solutions and APrevent.
Chemo Mouthpiece offers Chemo Mouthpiece Device and Patient Kit.